CNS Pharmaceuticals
CNSP
CNSP
7 hedge funds and large institutions have $75.3K invested in CNS Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
Holders
7
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$26.5K | |
| 2 | +$23.5K | |
| 3 | +$16K | |
| 4 |
Goldman Sachs
New York
|
+$3.68K |
| 5 |
Jane Street
New York
|
+$3.02K |
Top Sellers
| 1 | -$223K | |
| 2 | -$6 | |
| 3 | -$3 | |
| 4 |
Morgan Stanley
New York
|
-$3 |
| 5 |
PA
Parallel Advisors
San Francisco,
California
|
-$2 |